TY  - JOUR
AU  - Sixto-López, Yudibeth
AU  - Gómez-Vidal, José Antonio
AU  - de Pedro, Nuria
AU  - Bello, Martiniano
AU  - Rosales-Hernández, Martha Cecilia
AU  - Correa-Basurto, José
PY  - 2020
DO  - 10.1038/s41598-020-67112-4
UR  - http://hdl.handle.net/10668/15838
T2  - Scientific reports
AB  - Histone deacetylases (HDACs) belong to a family of enzymes that remove acetyl groups from the ɛ-amino of histone and nonhistone proteins. Additionally, HDACs participate in the genesis and development of cancer diseases as promising therapeutic...
LA  - en
KW  - Antineoplastic Agents
KW  - Breast Neoplasms
KW  - Carcinoma, Hepatocellular
KW  - Cell Line, Tumor
KW  - Cell Proliferation
KW  - Drug Design
KW  - Drug Screening Assays, Antitumor
KW  - Female
KW  - Hep G2 Cells
KW  - Histone Deacetylase 1
KW  - Histone Deacetylase 6
KW  - Histone Deacetylase Inhibitors
KW  - Histone Deacetylases
KW  - Humans
KW  - Hydroxamic Acids
KW  - Liver Neoplasms
KW  - MCF-7 Cells
KW  - Molecular Docking Simulation
KW  - Repressor Proteins
TI  - Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines.
TY  - research article
VL  - 10
ER  -